Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients-Reference-Cited by-同舟云学术

Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients

Published:2005 Issue:1 Volume:77 Page:23-28
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Rodes Berta,García Federico,Gutierrez Carolina,Martinez-Picado Javier,Aguilera Antonio,Saumoy Maria,Vallejo Alex,Domingo Pere,Dalmau David,Ribas Maria Angels,Blanco José Luis,Pedreira José,Perez-Elias Maria Jesús,Leal Manuel,de Mendoza Carmen,Soriano Vincent,

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference37 articles.

1. Evolution of Phenotypic Drug Susceptibility and Viral Replication Capacity during Long-Term Virologic Failure of Protease Inhibitor Therapy in Human Immunodeficiency Virus-Infected Adults

2. Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors

3. Role of Baseline Human Immunodeficiency Virus Genotype as a Predictor of Viral Response to Tenofovir in Heavily Pretreated Patients

4. Extent and Importance of Cross-Resistance to Efavirenz after Nevirapine Failure

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of virological response to therapy and resistance profile in treatment-experienced and naive HIV-1 infected Romanian patients receiving regimens containing darunavir boosted with ritonavir or cobicistat;Biomedicine & Pharmacotherapy;2022-06

2. The Estimation of Transmitted Drug Resistance Mutation Strains Probability in the Treatment of HIV Using the Beta-Binomial Model;AIDS Research and Human Retroviruses;2021-06-01

3. Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial;Clinical Infectious Diseases;2018-07-28

4. The association between detected drug resistance mutations and CD4+ T-cell decline in HIV-positive individuals maintained on a failing treatment regimen;Antiviral Therapy;2017

5. Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial;HIV Medicine;2015-02-25